Cost-Effectiveness Acceptability Curves Revisited Maiwenn J. Al Practical Application 14 December 2012 Pages: 93 - 100
Retigabine for the Adjunctive Treatment of Adults with Partial-Onset Seizures in Epilepsy with and without Secondary Generalization Dawn CraigStephen RiceNerys Woolacott Review Article 23 January 2013 Pages: 101 - 110
Acknowledging Patient Heterogeneity in Economic Evaluation Janneke P. C. GruttersMark SculpherManuela A. Joore Systematic Review 04 January 2013 Pages: 111 - 123
A Systematic Review of the Cost Effectiveness of Herpes Zoster Vaccination Thomas D. SzucsAlena M. Pfeil Systematic Review 19 January 2013 Pages: 125 - 136
When Does NICE Recommend the Use of Health Technologies Within a Programme of Evidence Development? Louise LongworthJiHee YounKarl Claxton Systematic Review Open access 04 January 2013 Pages: 137 - 149
Improving Clinical Reality in Chronic Obstructive Pulmonary Disease Economic Modelling Yumi AsukaiMichael BaldwinDavid Price Original Research Article Open access 04 January 2013 Pages: 151 - 161
Valuing Benefits to Inform a Clinical Trial in Pharmacy Michela TinelliMandy RyanAnthony Scott Original Research Article 15 December 2012 Pages: 163 - 171
Comparing Subsidized Access to Medicines Across Payer Systems Michael WonderRichard Milne Correspondence 08 December 2012 Pages: 173 - 174
The Authors’ Reply to Wonder and Milne: “Comparing Subsidized Access to Medicines Across Payer Systems” Rajan RagupathyKatri AaltonenDavid Reith Correspondence 15 December 2012 Pages: 175 - 176